Group 1 - The stock price of P3 Health Partners Inc. (PIII) has experienced a bearish trend, losing 14.2% over the past two weeks, but a hammer chart pattern suggests a potential trend reversal as buying interest may be increasing [1] - The hammer chart pattern indicates a possible bottoming out of the stock price, with reduced selling pressure, signaling that bulls may be gaining control [2] - There has been a significant upward trend in earnings estimate revisions for PIII, with a 17.9% increase in the consensus EPS estimate over the last 30 days, indicating improved earnings expectations from analysts [3] Group 2 - PIII holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [3] - The Zacks Rank serves as a timing indicator, suggesting that the company's prospects are beginning to improve, further supporting the case for a potential trend reversal [3]

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, inves ...

P3 Health Partners Inc. (NASDAQ:PIII) Q2 2024 Earnings Call August 7, 2024 4:30 PM ET Company Participants Ryan Halsted - Investor Relations Aric Coffman - Chief Executive Officer Atul Kavthekar - Chief Financial Officer Amir Bacchus - Chief Medical Officer Bill Bettermann - Chief Operating Officer Conference Call Participants Brooks O’Neil - Lake Street Capital Markets Josh Raskin - Nephron Research Jenny Shen - BTIG Ryan Langston - TD Cowen Jack Senft - William Blair Operator Good day, and welcome to the ...

Company Performance - P3 Health Partners Inc. reported a quarterly loss of $0.15 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.08, and compared to a loss of $0.09 per share a year ago, indicating an earnings surprise of -87.50% [1] - The company posted revenues of $379.16 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 4.02%, and showing an increase from year-ago revenues of $329.09 million [2] - Over the last four quarters, P3 Health Partners has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - P3 Health Partners shares have declined approximately 57% since the beginning of the year, contrasting with the S&P 500's gain of 9.9% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.04 on revenues of $368.5 million, and for the current fiscal year, it is -$0.28 on revenues of $1.53 billion [7] Industry Outlook - The Medical Info Systems industry, to which P3 Health Partners belongs, is currently ranked in the bottom 42% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - The outlook for the industry can significantly impact the performance of P3 Health Partners' stock, as research shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40033 P3 Health Partners Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | |--------------------------------- ...

Exhibit 99.1 P3 Health Partners Announces Second Quarter 2024 Results Management to Host Conference Call and Webcast August 7, 2024 at 4:30 PM ET HENDERSON, NV—August 7, 2024—P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2024. "In the second quarter, we experienced continued growth in our top line while simultaneously enhancing our balance s ...

P3 Health Partners (NASDAQ:PIII) stock is falling on Tuesday after the company sold shares and warrants to institutional investors in a recent offering. P3 Health Partners reveals in a filing with the Securities and Exchange Commission (SEC) that it issued roughly 67.4 million shares of PIII stock to institutional investors. These were sold at a price of $0.6270 each. Investors will note that each of these shares also comes with one warrant to purchase another share of PIII stock. These warrants have an exe ...

P3 Health Partners Inc. (NASDAQ:PIII) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Ryan Halsted - Gilmartin Group Sherif Abdou - Strategic Advisor Atul Kavthekar - CFO Amir Bacchus - CMO Aric Coffman - CEO Bill Bettermann - COO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Josh Raskin - Nephron Research Jenny Shen - BTIG Gary Taylor - TD Cowen Jack Senft - William Blair Operator Hello and welcome to the P3 Health Partners' First Quarter 2024 Earning ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40033 P3 Health Partners Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or orga ...

Exhibit 99.1 P3 Health Partners Announces First Quarter 2024 Results Dr. Aric Cof man joins P3 Health Partners as CEO Total revenue growth of 29% year-over-year Reaf irming 2024 guidance Anticipates reaching Adjusted EBITDA positive in 2024 Management to Host Conference Call and Webcast May 8, 2024 at 4:30 PM ET HENDERSON, NV—May 8, 2024—P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial res ...